Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells

European Journal of Pharmacology

Volumn 382, Issue 2, 1999, Pages 111-117

  Kosonen, Outi ^a   Kankaanranta, Hannu ^a,b   Malo Ranta, Ulla ^a   Moilanen, Eeva ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adhesion; CD11 CD18; Nitric oxide (NO); Nitric oxide (NO) releasing compound

Indexed keywords

3 (3 CHLORO 2 METHYLPHENYL) 5 (4 METHYLBENZENESULFONYLIMINO) 1,2,3,4 OXATRIAZOLE; 3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; CD11 ANTIGEN; CD18 ANTIGEN; LINSIDOMINE; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL INTERACTION; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; ENDOTHELIUM CELL; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD11; ANTIGENS, CD18; CELL ADHESION; COCULTURE TECHNIQUES; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MOLSIDOMINE; NEUTROPHILS; NITRIC OXIDE DONORS; RABBITS; THIONUCLEOTIDES; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032856357     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00581-6     Document Type: Article

References (56)

1. Armstead V.E., Minchenko A.G., Schuhl R.A., Hayward R., Nossuli T.O., Lefer A.M. Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am. J. Physiol. 273:1997;H740-H746.
2. Arnaout A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 75:1990;1037-1050.
3. Arndt H., Russel J.B., Kurose I., Kubes P., Granger D.N. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology. 105:1993;675-680.
4. Axelsson K.L., Bornefeldt K.E., Norlander B., Wikberg J.E.S. Attomole sensitive radioimmunoassay for cyclic GMP. Second Messengers Phosphoproteins. 12:1988;145-154.
5. Bailey P.J., Fletcher D.S. Arthus phenomenon. Methods Enzymol. 162:1988;478-483.
6. Banick P.D., Chen Q., Xu Y.A., Thom S.R. Nitric oxide inhibits neutrophil ß2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J. Cell. Physiol. 172:1997;12-24.
7. Buonassisi V., Venter J.C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl. Acad. Sci. U.S.A. 73:1976;1612-1616.
8. Butt E., Nolte C., Schulz S., Beltman J., Beavo J.A., Jastorff B., Walter U. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP. Biochem. Pharmacol. 43:1992;2591-2600.
9. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
10. Corell T., Pedersen S.B., Lissau B., Moilanen E., Metsä-Ketelä T., Kankaanranta H., Vuorinen P., Vapaatalo H., Rydell E., Andersson R., Marcinkiewicz E., Korbut R., Gryglewski R. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol. 46:1994;553-566.
11. Crow J.P., Beckman H.S. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. Immunol. 196:1995;57-73.
12. Davenpeck K.L., Gauthier T.W., Lefer A.M. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology. 107:1994;1050-1058.
13. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17(Suppl. 3):1991;S25-S33.
14. Fukuda H., Sawa Y., Kadoba K., Taniguchi K., Shimazaki Y., Matsuda H. Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation. 92(Suppl. II):1995;II413-II416.
15. Gaboury J., Woodman R.C., Granger D.N., Reinhardt P., Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am. J. Physiol. 265:1993;H862-H867.
16. Gamble J.R., Harlan J.M., Klebanoff S.J., Vadas M.A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. U.S.A. 82:1985;8667-8671.
17. Grisham M.B., Granger D.N., Lefer D.J. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radical Biol. Med. 25:1998;404-433.
18. Grisham M.B., Jourd'Heuil D., Wink D.A. Nitric oxide: I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276:1999;G315-G321.
19. Gryglewski R.J., Palmer R.M., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
20. Hickey M.J., Kubes P. Role of nitric oxide in regulation of leukocyte-endothelial cell interactions. Exp. Physiol. 82:1997;339-348.
21. Hogg N., Darley-Usmar V.M., Wilson M.T., Moncada S. Production of hydroxyl radical from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281:1992;419-424.
22. Holm P., Kankaanranta H., Metsä-Ketelä T., Moilanen E. Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur. J. Pharmacol. 346:1998;97-102.
23. Holm P., Kankaanranta H., Oja S.S., Knowles R.G., Moilanen E. No detectable NO synthesis from L-arginine or N(G)-hydroxy-L-arginine in fMLP-stimulated human blood neutrophils despite production of nitrite, nitrate, and citrulline from N(G)-hydroxy-L-arginine. J. Leukocyte Biol. 66:1999;127-134.
24. Järvinen T.A.H., Moilanen T., Järvinen T.L.N., Moilanen E. Nitric oxide mediates interleukin-1-induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Med. Inflamm. 4:1995;107-111.
25. Kankaanranta H., Rydell E., Petersson A.S., Holm P., Moilanen E., Corell T., Karup G., Vuorinen P., Pedersen S.B., Wennmalm A., Metsä-Ketelä T. Nitric oxide donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharmacol. 117:1996;401-406.
26. Karup G., Preikschat H., Wilhelmsen E.S., Pedersen S.B., Marcinkiewicz E., Cieslik K., Gryglewski R. Mesoionic oxatriazole derivatives: a new group of NO donors. Pol. J. Pharmacol. 46:1994;541-552.
27. Kosonen O., Kankaanranta H., Vuorinen P., Moilanen E. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. Eur. J. Pharmacol. 337:1997;55-61.
28. Kosonen O., Kankaanranta H., Lähde M., Vuorinen P., Ylitalo P., Moilanen E. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism. J. Pharmacol. Exp. Ther. 286:1998;215-220.
29. Kosonen O., Kankaanranta H., Malo-Ranta U., Ristimäki A., Moilanen E. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells. Br. J. Pharmacol. 125:1998;247-254.
30. Kubes P., Suzuki M., Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4651-4655.
31. Kubes P., Kanwar S., Niu X.-F., Gaboury J.P. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
32. Kubes P., Kurose I., Granger D.N. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267:1994;H931-H937.
33. Kurose I., Kubes P., Wolf R., Anderson D.C., Paulson J., Miyasaka M., Granger D.N. Inhibition of nitric oxide production. Mechanism of vascular albumin leakage. Circ. Res. 73:1993;164-171.
34. Kurose I., Wolf R., Grisham M.B., Granger D.N. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74:1994;376-382.
35. Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc. Res. 32:1996;743-751.
36. Lefer A.M., Lefer D.J. Nitric oxide: II. Nitric oxide protects in intestinal inflammation. Am. J. Physiol. 276:1999;G572-G575.
37. Liu G.-L., Christopher T.A., Lopez B.L., Gao F., Guo Y., Gao E., Knuettel K., Feelisch M., Ma X.L. SP/W-5186, a cysteine-containing nitric oxide donor, attenuates postischemic myocardial injury. J. Pharmacol. Exp. Ther. 287:1998;527-537.
38. Lo S.K., Detmers P.A., Levin S.M., Wright S.D. Transient adhesion of neutrophils to endothelium. J. Exp. Med. 169:1989;1779-1793.
39. Malo-Ranta U., Ylä-Herttuala S., Metsä-Ketelä T., Jaakkola O., Moilanen E., Vuorinen P., Nikkari T. Nitric oxide donor GEA 3162 inhibits endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 337:1994;179-183.
40. Menegazzi R., Cramer R., Patriarca P., Scheurich P., Dri P. Evidence that tumor necrosis factor alpha (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood. 84:1994;187-293.
41. Miller J.P., Boswell K.H., Muneyama K., Simon L.N., Robins R.K., Shuman D.A. Synthesis and biochemical studies of various 8-substituted derivatives of guanosine 3′,5′-cyclic phosphate, inosine 3′,5′-cyclic phosphate, and xanthosine 3′,5′-cyclic phosphate. Biochemistry. 12:1973;5310-5319.
42. Moilanen E., Vapaatalo H. Nitric oxide in inflammation and immune response. Ann. Med. 27:1995;359-367.
43. 4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents Actions. 24:1988;387-394.
44. Moilanen E., Vuorinen P., Kankaanranta H., Metsä-Ketelä T., Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. Br. J. Pharmacol. 109:1993;852-858.
45. Moilanen E., Whittle B.R.J., Moncada S. Nitric oxide as a factor in inflammation. Gallin J.I., Snyderman R. Inflammation: Basic Principles and Clinical Correlates. 3rd edn. 1999;787-800 Lippincott Williams & Wilkins, Philadelphia.
46. Niu X.F., Smith C.W., Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1994;1133-1140.
47. Niu X.F., Ibbotson G., Kubes P. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ. Res. 79:1996;992-999.
48. Ohashi Y., Kawashima S., Hirata K.I., Akita H., Yokoyama M. Nitric oxide inhibits neutrophil adhesion to cytokine-activated cardiac myocytes. Am. J. Physiol. 272:1997;H2807-H2814.
49. Philips M.R., Buyon J.P., Winchester R., Weissmann G., Abramson S.B. Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. J. Clin. Invest. 82:1988;495-501.
50. Schleiffenbaum B., Moser R., Patarroyo M., Fehr J. The cell surface glycoprotein Mac-1 (CD11b/CD18) mediates neutrophil adhesion and modulates degranulation independently of its quantitative cell surface expression. J. Immunol. 142:1989;3537-3545.
51. Spiecker M., Darius H., Kaboth K., Hubner F., Liao J.K. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukocyte Biol. 63:1998;732-739.
52. Recommended methods for the determination of four enzymes in blood. Scand. J. Clin. Lab. Invest. 33:1974;291-306.
53. Tsujimoto M., Yokota S., Vilcek J., Weissmann G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochem. Biophys. Res. Commun. 137:1986;1094-1100.
54. Vedder N.B., Harlan J.M. Increased surface expression of CD11b/CD18 (Mac-1) is not required for stimulated neutrophil adherence to cultured endothelium. J. Clin. Invest. 81:1988;676-682.
55. Vilpo J.A., Vilpo L.M., Vuorinen P., Moilanen E., Metsä-Ketelä T. Cytotoxicity of mesoionic oxatriazoles: a novel series of nitric oxide donors. Moncada S., Feelisch M., Busse R., Higgs E.A. The Biology of Nitric Oxide. 4:1994;286-291 Portland Press, London.
56. Virta M., Karp M., Vuorinen P. Nitric oxide donor-mediated killing of bioluminescent Escherichia coli. Antimicrob. Agents Chemother. 38:1994;2775-2779.